Amplification of chromosome 17 centromere (CEP17) in breast cancer patients with a result of HER2 2+ by immunohistochemistry.

CONCLUSION: Patients with amplification of CEP17 had a co-amplified HER2 and were more commonly HER2+, LN positive and grade 3 in the nuclear component of grade.
PMID: 31977265 [PubMed - as supplied by publisher]

Source: Cancer Investigation - January 26, 2020 Category: Cancer & Oncology Tags: Cancer Invest Source Type: research